English Funding Rejection For Lynparza Triggers Concern Over ‘Double Counting’ Costs

Male doctor/nurse wearing blue scrubs, with a stethoscope around his neck and holding a Union Jack money purse.
NICE says Lynparza is too expensive for treating prostate cancer • Source: Alamy

More from Market Access

More from Pink Sheet